Institut Curie

This study tested an experimental drug called PF-05212384 in people with certain aggressive leukemias or related bone marrow diseases. The trial aimed to see if the drug could shrink or control the cancer. Only 10 people took part, and the study was stopped early, so results are …

This study tested a new drug called PLX038 in 14 people with advanced triple-negative breast cancer that had already been treated. The goal was to see if the drug could shrink tumors. The trial was stopped early, so results are limited.

This early-phase study tested a combination of two experimental drugs (tuvusertib and PLX038) in people with advanced solid tumors that could not be cured. The goal was to find a safe dose and see if the drugs could shrink tumors. Only 10 people took part before the study was sto…

This study looked at whether special hemostatic dressings can reduce bleeding when changing bandages on malignant wounds (cancer sores) compared to regular dressings. It involved 4 adults with wounds at least 10 cm² who had a bleeding episode during a hospital visit. The goal was…

This study looked at whether measuring tumor DNA in the blood of cervical cancer patients can help find small amounts of cancer that have spread early on. Researchers enrolled 26 patients with cervical cancer at any stage before treatment. They collected blood samples over time t…